Valuation : VolitionRx Limited

Market Cap 49.65L 42.73L 40.2L 36.72L 68.69L 47Cr 68.88L 4.75Cr 1.84Cr 24Cr 1.86Cr 1.82Cr 77Cr P/E 2026 *
-0.17x
P/E 2027 * -0.35x
Enterprise Value 49.65L 42.73L 40.2L 36.72L 68.69L 47Cr 68.88L 4.75Cr 1.84Cr 24Cr 1.86Cr 1.82Cr 77Cr EV / Sales 2026 *
1.99x
EV / Sales 2027 * 0.94x
Free-Float
85%
Yield 2026 *
-
Yield 2027 * -
1 day-0.09%
1 week-22.19%
Current month-19.43%
1 month-55.49%
3 months-82.52%
6 months-91.35%
Current year-93.16%
1 week 0.33
Extreme 0.33
0.45
1 month 0.33
Extreme 0.3269
0.81
Current year 0.33
Extreme 0.3269
7.73
1 year 0.33
Extreme 0.3269
14.8
3 years 0.33
Extreme 0.3269
27.6
5 years 0.33
Extreme 0.3269
82.8
10 years 0.33
Extreme 0.3269
136.8
Manager TitleAgeSince
Chief Executive Officer 55 06/10/2011
Director of Finance/CFO 56 01/02/2021
Chief Tech/Sci/R&D Officer 49 01/04/2024
Director TitleAgeSince
Director/Board Member 55 06/10/2011
Director/Board Member 77 06/10/2011
Director/Board Member 64 09/10/2019
Date Insider Type Main position Quantity % Market Cap. Importance
17/03/26
Concord International, Inc.
OtherCompany 0 0% -
17/03/26 Tax

Executive/Senior Manager

5,251 0.0039%
17/03/26 Tax

General Counsel

7,003 0.0052%
Change 5-day change 1-year change 3-year change Capi.($)
-0.09%-22.19%-97.25%-98.64% 49.65L
+1.03%+9.74%+299.55%+42.93% 398.16Cr
-1.18%-3.61%+86.48%+256.53% 387.5Cr
-4.79%-1.87%+34.93%+59.29% 341.9Cr
+2.05%+2.19%+288.40%+422.92% 263.22Cr
-1.65%-6.73%-26.25%-32.04% 210.75Cr
-3.49%+10.28%+54.60% - 175.25Cr
-0.68%-4.69%+210.17%-28.93% 109.06Cr
+1.11%-10.52%+24.12%+41.15% 107.93Cr
-1.55%-11.92%+9.29%+49.84% 61Cr
Average -0.92%-2.82%+88.40%+79.23% 205.51Cr
Weighted average by Cap. -1.05%+0.77%+131.73%+130.65%

Financials

2026 *2027 *
Net sales 24.91L 21.43L 20.16L 18.42L 34.46L 24Cr 34.55L 2.38Cr 92.46L 12Cr 93.52L 91.48L 39Cr 52.67L 45.32L 42.64L 38.95L 72.87L 50Cr 73.06L 5.04Cr 1.96Cr 26Cr 1.98Cr 1.93Cr 82Cr
Net income -2.16Cr -1.86Cr -1.75Cr -1.6Cr -2.99Cr -204.16Cr -3Cr -21Cr -8.03Cr -104.75Cr -8.12Cr -7.94Cr -337.45Cr -1.84Cr -1.58Cr -1.49Cr -1.36Cr -2.55Cr -173.9Cr -2.56Cr -18Cr -6.84Cr -89Cr -6.92Cr -6.77Cr -287.44Cr
Net Debt - -
Logo VolitionRx Limited
VolitionRx Limited is a multi-national company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer, and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.
Employees
57
Date Price Change Volume
04/26/04 $0.3496 -0.09% 11,73,742
03/26/03 $0.3499 -7.04% 20,01,342
02/26/02 $0.3764 -4.52% 19,17,099
01/26/01 $0.3942 -9.15% 23,44,492
31/26/31 $0.4339 -3.43% 50,10,871
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
0.3496USD
Average target price
16.57USD
Spread / Average Target
+4,638.56%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VNRX Stock